Your browser doesn't support javascript.
loading
EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.
Tan, Shengjiang; Kermasson, Laëtitia; Hoslin, Angela; Jaako, Pekka; Faille, Alexandre; Acevedo-Arozena, Abraham; Lengline, Etienne; Ranta, Dana; Poirée, Maryline; Fenneteau, Odile; Ducou le Pointe, Hubert; Fumagalli, Stefano; Beaupain, Blandine; Nitschké, Patrick; Bôle-Feysot, Christine; de Villartay, Jean-Pierre; Bellanné-Chantelot, Christine; Donadieu, Jean; Kannengiesser, Caroline; Warren, Alan J; Revy, Patrick.
Afiliação
  • Tan S; Cambridge Institute for Medical Research, Cambridge, United Kingdom.
  • Kermasson L; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Hoslin A; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Jaako P; INSERM Unité Mixte de Recherche 1163, Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le cancer, Paris, France.
  • Faille A; Paris Descartes-Sorbonne Paris Cité University, Imagine Institute, Paris, France.
  • Acevedo-Arozena A; Medical Research Council Mammalian Genetics Unit, Harwell, United Kingdom.
  • Lengline E; Cambridge Institute for Medical Research, Cambridge, United Kingdom.
  • Ranta D; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Poirée M; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Fenneteau O; Cambridge Institute for Medical Research, Cambridge, United Kingdom.
  • Ducou le Pointe H; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
  • Fumagalli S; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Beaupain B; Medical Research Council Mammalian Genetics Unit, Harwell, United Kingdom.
  • Nitschké P; Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain.
  • Bôle-Feysot C; Instituto de Tecnologías Biomédicas, Universidad de La Laguna, La Laguna, Spain.
  • de Villartay JP; Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas, La Laguna, Spain.
  • Bellanné-Chantelot C; Department of Hematology, CRNMR Aplasie Médullaire, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Donadieu J; Department of Haematology, Centre Hospitalier Universitaire de Nancy, Nancy, France.
  • Kannengiesser C; Department of Pediatric Hematology-Oncology, Centre Hospitalier Universitaire Lenval, Nice, France.
  • Warren AJ; Assistance Publique-Hôpitaux de Paris, Laboratory of Hematology, Robert Debré University Hospital, Paris, France.
  • Revy P; Radiology Department, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Blood ; 134(3): 277-290, 2019 07 18.
Article em En | MEDLINE | ID: mdl-31151987
ABSTRACT
Shwachman-Diamond syndrome (SDS) is a recessive disorder typified by bone marrow failure and predisposition to hematological malignancies. SDS is predominantly caused by deficiency of the allosteric regulator Shwachman-Bodian-Diamond syndrome that cooperates with elongation factor-like GTPase 1 (EFL1) to catalyze release of the ribosome antiassociation factor eIF6 and activate translation. Here, we report biallelic mutations in EFL1 in 3 unrelated individuals with clinical features of SDS. Cellular defects in these individuals include impaired ribosomal subunit joining and attenuated global protein translation as a consequence of defective eIF6 eviction. In mice, Efl1 deficiency recapitulates key aspects of the SDS phenotype. By identifying biallelic EFL1 mutations in SDS, we define this leukemia predisposition disorder as a ribosomopathy that is caused by corruption of a fundamental, conserved mechanism, which licenses entry of the large ribosomal subunit into translation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Alongamento de Peptídeos / Fatores de Iniciação de Peptídeos / Ribonucleoproteína Nuclear Pequena U5 / Síndrome de Shwachman-Diamond / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Animals / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Alongamento de Peptídeos / Fatores de Iniciação de Peptídeos / Ribonucleoproteína Nuclear Pequena U5 / Síndrome de Shwachman-Diamond / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adolescent / Animals / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article